Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Molecular Vision|April 10, 2004
Exclusion of 14 candidate loci for primary open angle glaucoma in Finnish familiesSusanna Lemmelä, Tero Ylisaukko-oja, Eva Forsman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Tobacco withdrawal in individuals suffering from mental disorders]Jaana Keto, Nina Rautio, Tero Ylisaukko-oja, et al.
Nordic Journal of Psychiatry|August 13, 2013
Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in FinlandTero Kujanpää, Tero Ylisaukko-Oja, Jari Jokelainen, et al.
Substance Abuse Treatment, Prevention, and Policy|November 4, 2015
Physicians discuss the risks of smoking with their patients, but seldom offer practical cessation supportJaana Keto, Jari Jokelainen, Markku Timonen, et al.
Human Genetics|November 5, 2003
Identification of two AGTR2 mutations in male patients with non-syndromic mental retardationTero Ylisaukko-oja, Karola Rehnström, Raija Vanhala, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 28, 2007
No association between common variants in glyoxalase 1 and autism spectrum disordersKarola Rehnström, Tero Ylisaukko-Oja, Raija Vanhala, et al.
Autism Research : Official Journal of the International Society for Autism Research|April 11, 2009
Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autismJoni A Turunen, Karola Rehnström, Helena Kilpinen, et al.
Scandinavian Journal of Gastroenterology|June 22, 2021
Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world settingSara Kolehmainen, Tero Ylisaukko-Oja, Jari Jokelainen, et al.
Scandinavian Journal of Gastroenterology|December 20, 2021
Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practiceTero Ylisaukko-Oja, Minna Puttonen, Jari Jokelainen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 30, 2022
Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register studyAino Vesikansa, Olli Halminen, Juha Mehtälä, et al.
Pageof 5